Attitudinal dimensions that determine pharmacists' decisions to support DTCA of prescription medication

Drug Information Journal

Volumn 34, Issue 1, 2000, Pages 103-114

  Desselle, Shane Paul ^a   Aparasu, Rajender ^b  

^a DUQUESNE UNIVERSITY   (United States)

^b SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Attitudes; Consumer knowledge; Direct to consumer advertising; Factor analysis; Pharmacist patient communication

Indexed keywords

DRUG;

ADULT; ADVERTIZING; ARTICLE; ATTITUDE; DRUG INDUSTRY; FACTORIAL ANALYSIS; FEMALE; HUMAN; MALE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0034045315     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400114     Document Type: Article

References (40)

1. Ruby LA, Montagne M. Direct-to-consumer advertisements: A case study of the Rogaine® campaign. J Pharm Mark Manage. 1991;6:21-32.
2. Gebhart F. Annual Rx survey: The new golden age. Drug Top. 1998;142:71-72, 74, 76, 83.
3. Conlan MF. In-your-face pharmacy. Drug Top. 1996; 140:92-94, 97, 98.
4. Schwartz H. On the money. Pharm Exec. 1997; (Oct):26, 28, 30.
5. Sherr MK, Huffman DC. Physicians - Gatekeepers to DTC success. Pharm Exec. 1997;(Oct):56-8, 62, 66.
6. Friedler E. The evolving doctor-patient to provider-consumer relationship. J Fam Pract. 1997;45:485.
7. Wenneberg JE. Health care reform and professionalism. Inquiry. 1993;31:296-302.
8. Haug MR, Lavin B. Practitioner or patient - Who's in charge? J Health Soc Behav. 1981;22:212-229.
9. Haug MR, Lavin B. Consumerism in Medicine: Challenging Physician Authority. Beverly Hills, CA: Sage; 1983.
10. Brennan PF, Strombom I. Improving health care by understanding patient preferences: the role of computer technology. J Am Med Inform Assoc. 1998;5: 257-262.
11. Gould SJ. Consumer attitudes toward health and health care: A differential perspective. J Consum Affairs. 1988;22:96-118.
12. Nordenberg T. Direct to you - TV drug ads that make sense. FDA Consum. 1998;32 (Jan-Feb):7-10.
13. Bradley LR, Zito JM. Direct-to-consumer prescription drug advertising. Med Care. 1997;35:86-92.
14. Kessler DA, Pines WL. The federal regulation of prescription drug advertising and promotion. JAMA. 1990;264:2409-2415.
15. Anon. Direct-to-consumer advertising debated; APhA endorses some forms. Am Pharm. 1988;NS28(11): 10-11.
16. Pierpaoli PG. ASHP's position on direct-to-consumer advertising of prescription drug products. Am J Hosp Pharm. 1986;43:1763-1765.
17. American Medical Association. House of Delegates Report XX. Chicago, Ill. American Medical Association; June 1992.
18. Christensen TP, Ascione FJ, Bagozzi RP. Understanding how elderly patients process drug information: A test of a theory of information processing. Pharm Res. 1997;14:1589-1596.
19. Lipsky MS, Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract. 1997;45:495-499.
20. Kier KL, Kucukarslan SN. Direct-to-consumer advertising of prescription drugs: Implications to pharmacy practice. Ohio Pharm. 1992;41 (Jan):21, 24.
21. Kopp SW. Direct-to-consumer advertsiing and consumer prescription prices. Drug Inf J. 1996;30: 59-65.
22. T Hoen E. Direct-to-consumer advertising: For better profits or for better health? Am J Health-Syst Pharm. 1998;55:594-597.
23. Feisullin S, Sause RB. Update on direct-to-consumer advertising of prescription drugs. Am Pharm. 1991; NS31(7):47-52.
24. Madell R. DTC unleashed - Reviews and reactions. Pharm Exec. 1997(Oct):68-70, 72, 74.
25. Perri M, Nelson AA. An exploratory analysis of consumer recognition of direct-to-consumer advertising of prescription medications. J Health Care Mark. 1987;7:9-17.
26. Anon. Americans at risk from self-medication, survey reveals. Am J Health-Syst Pharm. 1997;54:2664, 2666.
27. Madhavan S. The on-going dilemma of direct-to-consumer advertising of prescription drugs. West Virginia Pharmacy. 1989;13:8-10.
28. Talley CR. Direct-to-consumer prescription drug advertising. Am J Health Syst Pharm. 1997;54:2181.
29. Medication compliance and the elderly. J Pharmacoepidemiol. 1995;4:7-14.
30. Kushner D. Don't advertise prescription drugs to public, mfrs are urged. Am Drug. 1986;193(Mar): 126, 128, 130, 132.
31. Robinson B. Consumer prescription ads viewed warily by pharmacists. Drug Top. 1986;130 (Feb 17):94, 96.
32. Southwick K. Battling allergy therapies focus on consumer choice. Manage Health. 1997;7 (Apr): 54-58.
33. Anon. Two-third of Rph's and MD's object to makers' promotion of Rx drugs to the public. Am Drug. 1982;186 (Oct):14, 16, 21-22.
34. Basara LR. Practical considerations when evaluating direct-to-consumer advertising as a marketing strategy for prescription medications. Drug Inf J. 1994; 28:461-470.
35. SAS/STAT User's Guide Release 6.03 Edition Cary: SAS Institute, Inc., 1988.
36. Waltern NJ, Ferrante-Wallace J. Lessons from non-response in consumer market survey. J Health Care Market. 1985;5:17-28.
37. Nunnally JC. Psychometric Theory. New York; McGraw Hill; 1976.
38. Carmines EG, Zeller RA. Reliability and Validity Assessment. Beverly Hills, CA: Sage Publications; 1987.
39. Anon. Physicians say direct-to-consumer advertising affects patient behavior. Am J Hosp Pharm. 1993; 50:1329.
40. Maddox LM, Katsanis LP. Direct-to-consumer advertising of prescription drugs in Canada: its potential effect on patient-physician interaction. J Pharm Mark Manage. 1997; 12 (1):1-21.